Table 2.
Laboratory parameters of patients with vitiligo compared with controls
| Parameter | Patient group (n=49) | Control group (n=36) | t | P |
|---|---|---|---|---|
| AMA (mg/ml) | ||||
| Range | 7.6-40.1 | 5.1-7.3 | 6.9634 | <0.001* |
| Mean±SD | 16.4±10.1 | 6.3±0.8 | ||
| C3 (mg/dl) | ||||
| Range | 16.3-286 | 50-146 | 0.3782 | >0.05 |
| Mean±SD | 111.5±155.8 | 103±30.5 | ||
| C4 (mg/dl) | ||||
| Range | 16.7-86.6 | 9.2-48 | 5.8357 | <0.001* |
| Mean±SD | 35.3±15.3 | 19.6±9.4 | ||
| ANA | ||||
| Range | 0.58-13.56 | 0.51-0.9 | 4.9862 | <0.001* |
| Mean±SD | 2.1±1.9 | 0.78±0.11 |
*P<0.05 was considered statistically significant. AMA: Antimelanocyte antibody, ANA: Antinuclear antibody, C3: Complement 3, C4: Complement 4, SD: Standard deviation